Vanda Pharmaceuticals buy StockNews.com
Start price
04.03.23
/
50%
€5.90
Target price
04.03.24
-
Performance (%)
-34.24%
End price
05.03.24
€3.88
Summary
This prediction ended on 05.03.24 with a price of €3.88. The BUY prediction by StockNews_com for Vanda Pharmaceuticals performed very badly with a performance of -34.24%. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Vanda Pharmaceuticals | -3.175% | -3.175% | 46.635% | -3.175% |
| iShares Core DAX® | 1,60 % | -7,45 % | 3,04 % | 46,26 % |
| iShares Nasdaq 100 | -0,73 % | -1,86 % | 15,42 % | 72,33 % |
| iShares Nikkei 225® | 1,30 % | -6,80 % | 34,31 % | 52,28 % |
| iShares S&P 500 | -0,39 % | -2,34 % | 9,91 % | 55,10 % |
Comments by StockNews_com for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for VNDA provided by MarketBeat
In the thread Trading Vanda Pharmaceuticals
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten